The assay performance and its potential clinical application was further evaluated by testing DBS reference samples with known copy numbers of the SMN1 and SMN2 genes, archived DBS specimens with confirmed diagnosis of SMA and contrived SCID and XLA positive DBS samples. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.